SHC
Sotera Health Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.64
−1.40%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$18.08
From 52W high−9.86%
Volume1.61M
Market cap$5.03B
P/E (TTM)30.8x
P/S (TTM)4.1x
Div yield—
Key dataOct 19, 2026
Open
$18.08
From 52W high
−9.86%
Volume
1.61M
Market cap
$5.03B
ValuationView details →
P/E (Fwd)
16.8x
EV/EBITDA
13.0x
P/E (TTM)
30.8x
RSI (14)
41.6
MomentumView details →
1D Return
−1.40%
YTD Return
+0.85%
SummaryUpdated Jun 1, 2026
Sotera Health Company (NASDAQ:SHC) is a mission-critical sterilization and laboratory testing services provider that went public in November 2020. Founded in 2017 and headquartered in Broadview Heights, Ohio, the company operates through three main business segments serving the medical device, pharmaceutical, and food industries. Sotera Health has achieved 19 consecutive years of revenue growth and plays an essential role in ensuring the safety and efficacy of medical products before they reach patients and consumers.
Similar companies
Latest newsMore news →
Bank of America Corp DE increased its stake in Sotera Health Company by 332.7% during the quarter, acquiring an additional 991,620 shares, according to a Form 13F filing.61d agoJames C. Neary resigned as Class I director of Sotera Health Co, effective August 13, 2026.67d agoSotera Health Co reported Q2 2026 financial results with revenue of $321.4 million, net income of $53.6 million, and diluted EPS of $0.19.75d ago